Frequently Asked Questions
To sign up for future studies, please enter your information here. We'll reach out when we begin recruitment. You'll then be asked a few screening questions to see if you qualify. Thanks for your interest in helping us gather data on natural products!
Radicle Science validates natural product efficacy to differentiate your brand, build credibility, and drive revenue. We do this by reimagining the traditional pharmaceutical and academic research model to deliver rigorous health outcome data at a fraction of the time and cost. Our virtual, direct-to-consumer clinical trials offer the first ever path to natural product validation. Contact our team to learn more about what we do.
Radicle refers to the root of a plant, connecting to our mission to go back to the roots of mankind’s original medicines, heal with the roots of nature, and get to the root of the problem.
Said out loud, it sounds like "Radical Science.” This serves as a constant reminder of our audacious business model and our radically disruptive approach, balanced by our commitment to scientific rigor and evidence.
Radicle Science gives you differentiation and actionable insights by discovering how customers experience your natural products in the real world as well as in controlled trial settings. Our big data approach offers a unique analysis of demographic or behavioral variations. Our offerings are rigorously designed by experts, leverage a turnkey methodology, and provide actionable insights rapidly.
Radicle Real World™
Real-world evidence (RWE), straight from new customers, for an in-depth view of their product experiences.
Drives strategic business decisions
Guides target customer segmentation
Informs dose/usage recommendations
Randomized, blinded trial simultaneously testing multiple products (including formulations, form factors, and/or dosages) head-to-head to assess differential effects on a variety of need states and health outcomes.
Accelerates product development
Aligns products to use cases
Identifies opportunities for claims
A cross-sectional, single-point-in-time study to generate real-world evidence (RWE) on your products & customers
Leverages existing customers
Provides product differentiation
Builds Brand confidence
Contact our team to find out more about our research offerings and activities.
Jeffrey Chen, MD, MBA and Pelin Thorogood, M.Eng, MBA are the co-founders of Radicle Science. The Radicle Science team—from our founders and executive team to our researchers and advisors—is composed of renowned experts and trailblazers operating at the intersection of digital health, big data, and natural products. Our collective experience in clinical trials, big data and analytics, public health, pharma, FDA, and digital marketing power a transformative approach to clinical trials and health insight generation.
Radicle Science works with both brands and individuals. We are currently focusing on the CBD and cannabinoid industry and will expand over time to include other natural products such as medical cannabis, nootropics, and microbiome interventions
We have, in essence, democratized the clinical trial process, enabling any natural health product or brand big or small to undergo validation and prove their effectiveness against placebo control. We believe that rigorous clinical trial data + natural health products = democratized medicines for all future generations.
Radicle Science is currently focusing on brands that currently produce or are trying to develop high quality CBD or cannabinoid-based products.
Contact our team to learn more about how Radicle Science can help your brand differentiate itself, build credibility, and drive revenue.
Radicle Science has a singular vision –we will challenge the status quo by democratizing the clinical trial process and unleashing personalized health outcome data. Our vision is a future where affordable natural products are trusted by patients, recommended by healthcare providers, reimbursed by insurance, and used as widely as pharmaceutical drugs.
A benefit corporation, or B-corp, is a for-profit corporation recognized by the majority of U.S. states that is driven by both mission and profit. Shareholders hold the company accountable to produce a financial profit as well as a specified public benefit.
As a Delaware Public Benefit Corporation, our commitment to "increase public awareness of safe and affordable treatment options for the benefit of individuals who are in need of such treatments by studying and sharing objective health outcome data" is part of our corporate charter, as stated in our certificate of incorporation.